Precision Medicine in Inflammatory Bowel Diseases

Journal article

Publication Details

Author(s): Fischer S, Neurath M
Journal: Clinical Pharmacology & Therapeutics
Publication year: 2017
Volume: 102
Journal issue: 4
Pages range: 623-632
ISSN: 0009-9236


Inflammatory bowel diseases (IBDs) are a lifelong condition of chronic, recurrent inflammation in the gut. The introduction of immunomodulators and biologic agents markedly improved the treatment of IBDs. Therefore, the use of biologics became an essential element in the rational therapy of IBDs. Various substances are currently evaluated in clinical trials, addressing different target structures and offering further approaches in the field of IBD. Regarding the growing number of treatment options, the need for prediction of therapy response became a necessity and is the subject of the present research.

FAU Authors / FAU Editors

Fischer, Sören
Transfusionsmedizinische und Hämostaseologische Abteilung in der Chirurgischen Klinik
Neurath, Markus Prof. Dr.
Lehrstuhl für Innere Medizin I

How to cite

Fischer, S., & Neurath, M. (2017). Precision Medicine in Inflammatory Bowel Diseases. Clinical Pharmacology & Therapeutics, 102(4), 623-632.

Fischer, Sören, and Markus Neurath. "Precision Medicine in Inflammatory Bowel Diseases." Clinical Pharmacology & Therapeutics 102.4 (2017): 623-632.


Last updated on 2018-18-10 at 23:10